New compound outperforms pain drug by indirectly targeting calcium channels

A compound—one of 27 million screened in a library of potential new drugs—reversed four types of chronic pain in animal studies, according to new research led by NYU College of Dentistry’s Pain Research Center and published in the Proceedings of the National Academy of Sciences (PNAS).

Leave A Comment

Your email address will not be published. Required fields are marked *